Danielle Ellis

Creative - Digital Events & Engagement Specialist

Biological Sciences, B.Sc.

Danielle started her journey at AZoNetwork in 2021 as an Editor for News Medical after completing her degree in Biological Sciences from Cardiff University. Since then, she has progressed to become Editor-in-Chief of News Medical, as well as the Account Manager for a long-standing client. These opportunities have allowed her to diversify and develop her skills across project management and digital engagement, leading her to now head AZoNetwork's Webinars.

In her current role, Danielle oversees the planning, production, and promotion of live and on-demand webinars, collaborating closely with global clients to deliver impactful scientific content to targeted audiences.

Outside of work, Danielle volunteers for a local charity and enjoys spending time with her cat, listening to music and podcasts, and practicing yoga.

See less

Articles from Danielle

Neurological Narratives: A Journey into Women's Brain Health Research

This insightful interview explores the disparities in neurological care and the innovative strategies aimed at transforming research and treatment for better, inclusive health outcomes.

7 Mar 2024

Transforming Cancer Care: Aventa Genomics and the Future of Genomic Testing

In this interview, Chris Roberts of Aventa Genomics highlights the groundbreaking Aventa FusionPlus test, detailing its superior ability to detect gene fusions in cancer diagnostics and its pivotal role in advancing personalized oncology treatments.

16 Feb 2024

RNA Therapies in Liver Disease: Insights from Ochre Bio's CEO

In this interview, we speak with Jack O'Meara, co-founder and CEO of Ochre Bio, a pioneering force in liver disease treatment. O'Meara shares insights into Ochre Bio's innovative RNA therapies, their approach to tackling liver disease, and the company's vision for the future.

24 Jan 2024

Pioneering Genomic Progress: An Interview with Rami Mehio, Illumina's Software and Informatics Expert

In this interview, Rami Mehio, head of software and informatics at Illumina, shares his experiences and contributions to major genomic projects like the UK Biobank's whole genome sequencing. He discusses the challenges and innovations in genomic data analysis, highlighting Illumina's role in advancing genetic research and precision medicine.

15 Jan 2024

New hope for stroke patients: University of Cincinnati trial tests unique tongue exercise device

The Gardner Neuroscience Institute, supported by a $660,000 NIH grant, is launching a trial to test an at-home tongue endurance exercise aimed at improving swallowing function in stroke survivors.

11 Jan 2024

AI Integration in the Fight Against Age-Related Macular Degeneration

In this interview, Wen Hwa Lee, CEO, and Chief Scientist at Action Against Age-Related Macular Degeneration (AAAMD), offers an enlightening perspective on merging AI with ophthalmology to forge new paths in healthcare and drug discovery.

3 Jan 2024

Pioneering Visions: Michael Stryker's Contributions to Understanding the Visual Cortex

In this interview conducted at the Society for Neuroscience's Neuroscience 2023, we explore the fascinating world of neuroscience with Professor Michael Stryker, a leading expert with over four decades of groundbreaking research.

6 Dec 2023

Sir Peter Barnes on World COPD Day: Awareness, Advances, and the Road Ahead

In this interview, we delve into the remarkable journey of Professor Sir Peter Barnes, a leading figure in respiratory medicine.

15 Nov 2023

Early Detection and Gender Disparities in COPD

In this interview, Dr. MeiLan Han, a distinguished pulmonologist and Chief of the Division of Pulmonary and Critical Care at the University of Michigan, shares her profound insights into Chronic Obstructive Pulmonary Disease (COPD).

14 Nov 2023

Revolution by Evolution: Protein Science and its Impact on Drug Discovery

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Mark Abbott, the Managing Director of Peak Proteins, about protein science and its significance in drug discovery.

10 Nov 2023